Navigation Links


RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

12/17/2014
MARLBOROUGH, Mass. , Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: RXII ), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced completion of enrollment in its first Phase 2a study, RXI-109-1301.  The preliminary results... [Comments]

Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture

12/17/2014
KENNESAW, Ga. and RALEIGH, N.C. , Dec. 17, 2014 Clinical Trial Marketing Communications, LLC (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), two firms specializing in patient recruitment and retention for clinical trials announce that they have formed a joint venture called Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will provide a broad range... [Comments]

Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications

12/17/2014
HOUSTON , Dec. 17, 2014 PCCA received the Autism Hope Alliance's (AHA) Autism Approved ( http://bit.ly/1382OkS ) program seal for best practices in meeting needs in the autism community. The program highlights medical practices, materials and goods that meet strict criteria and are considered "autism-community friendly." Children affected by autism often have un... [Comments]

Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam

12/15/2014
LONDON , December 15, 2014 Registreer nu via  http://bit.ly/ag8Sypm14de Am 19. und 20. Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen (PMR) eingeladen, das Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ 2015 in Amsterdam zu besuchen. Diese Tagung soll dazu beitragen, der Aegate PMR Dienstleister Gemeinsch... [Comments]

MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis

12/15/2014
DUBLIN , Dec. 12, 2014 Research and Markets ( http://www.researchandmarkets.com/research/vt6973/mems_gyroscopes ) has announced the addition of the "MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 MEMS gyroscopes for tactical grade application... [Comments]

Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018

12/15/2014
DUBLIN , Dec. 12, 2014 Research and Markets ( http://www.researchandmarkets.com/research/bf3b6l/electrocardiogram ) has announced the addition of the "Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram Devices (ECG) sector is project... [Comments]

Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018

12/15/2014
DUBLIN , Dec. 12, 2014 Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ) has announced the addition of the "Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior Vena Cava (IVC) Filters sector is projected... [Comments]

Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018

12/15/2014
DUBLIN , Dec. 12, 2014 Research and Markets http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the "Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018"  report to their offering. Global Guidewires sector is projected to reach US$1.6 billion by 2016. T... [Comments]

BerGenBio Completes NOK90 Million Fundraising

12/15/2014
BERGEN, Norway , December 15, 2014 BerGenBio AS, a biopharmaceutical company focused on developing innovative drugs for aggressive drug resistant cancers, today announces that it has raised NOK90 million (c. $15 million) in a private placing from new and existing investors. BerGenBio will use the proceeds from the financing to support the development of its pipeline of inn... [Comments]

Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board.

12/15/2014
NEW YORK and HERZLIYA PITUACH, Israel , Dec. 15, 2014  Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: IMNP ) announced today that its Board of Directors has elected Mr. Daniel Kazado Chairman of the Board succeeding Dr. Daniel Teper who continues as Chief Executive Officer of Immune. Mr. Kazado has been a member of Immune's Board of Directors since... [Comments]

[previous] [next]
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Organization (NGO), sent over $3,000,000 of vitally needed medical supplies to ... ... -- In a continent often defined by man-made conflicts and natural ... success stories. Among the 53 countries in Africa there ...
... used as traditional remedies for hundreds of years. Among ... in treatment of hepatitis, inflammation, osteomyelitis and gynecological diseases ... barbata have growth inhibitory effects on a number ... of lung, breast and digestive system cancer, hepatoma, and ...
... Scantek Medical, Inc. (Pink Sheets: SKML)("Scantek") announced ... voluntary petition in the United States Bankruptcy Court pursuant ... States Code. Scantek also announced today that it ... Sensor product ("BreastCare") to a medical equipment supplier for ...
... genes initially appeared to be statistically significantly associated with ... individual studies are pooled, however, few DNA repair gene ... to a field synopsis published in the December 30 ... Cancer Institute. , Because DNA damage is associated ...
... didn,t halt women,s risk of developing disease , , TUESDAY, ... the supposed cancer-fighting powers of vitamins C and E, ... don,t prevent the disease in women. , And another ... new study found. , , "Simply taking antioxidant supplements ...
... Boston resident Barbara Gilchrest, MD, a member of ... and professor and chairman-emeritus of the Department of Dermatology ... recently named one of America,s Top Doctors by Castle ... recognized by consumers seeking high-quality medical care, is a ...
Cached Medicine News:Health News:Good News in Africa: Beyond the headlines 2Health News:Scantek Medical Files for Chapter 11 Voluntary Bankruptcy and Receives Orders for the Sale of BreastCare(TM) 2Health News:Few DNA repair genes maintain association with cancer in field synopsis 2Health News:Vitamins Fail to Prevent Cancer: Study 2Health News:Vitamins Fail to Prevent Cancer: Study 3Health News:BMC, Boston University School of Medicine dermatologist named one of America's Top Doctors 2
... Neonatal and Pediatric TRACH ... a multi access catheter ... lavage/irrigation port and locking ... sizes and packaging configurations. ...
... Stainless steel spiral reinforced. X-ray opaque. Super ... band. Single use. Adjustable Flange: The flange ... to suit the thickness of the cervical ... clockwise until the flange is tightly connected ...
... ULTRA® Suctionaid® tracheostomy tubes provide an additional ... from above the tracheostomy tube cuff. , ... tubes provide an additional lumen to permit ... tracheostomy tube cuff helping to reduce the ...
The soft silicone design promotes patient comfort. , ,Bivona® laryngectomy tubes feature a soft compliant silicone design for patient comfort....
Medicine Products:
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and ... addition of the "Inferior Vena Cava (IVC) Filters ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sector is projected to reach US$435 million by 2016. ... nearly 39% (2015) of the global value while ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  Immune ... announced today that its Board of Directors has elected Mr. ... Teper who continues as Chief Executive Officer of Immune. ... Directors since 2013. Immune,s new Chairman, Mr. ... interest of shareholders and to continue to support the strategic ...
(Date:12/15/2014)... Washington State are not the only ... Oregon , Alaska , and ... 2014 elections. Photo - http://photos.prnewswire.com/prnh/20141212/164152 ... The benefits of legalizing cannabis are manifold. There are the ... revenue for state and local governments, in addition to reduced ...
Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2
... , ST. LOUIS and MADRID, Oct. 13 CPhI ... member of the Sigma-Aldrich® Group (Nasdaq: SIAL ), ... in Cambridge, UK, have installed a new single crystal ... system, which can determine the crystal structures from the ...
... , EAST HANOVER, N.J., Oct. 12 Novartis Pharma AG ... rights to Fanapt(TM) (iloperidone), a new oral medication ... (FDA) for the acute treatment of adults with schizophrenia. Novartis ... early 2010. , As part of the agreement with ...
Cached Medicine Technology:SAFC Pharma Installs the Industry's First Commercial Dual Wavelength X-Ray Diffractometer 2SAFC Pharma Installs the Industry's First Commercial Dual Wavelength X-Ray Diffractometer 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 8